7 Ohio Cancer Docs Face Charges Over Drug Imports
The medicines have all been approved by the U.S. Food and Drug Administration, but bringing them in from abroad constitutes so-called misbranding, prosecutors said.
Authorities said the imported medications included three cancer drugs — Sanofi-Aventis SA’s Taxotere and Eloxatin, and Eli Lilly and Co.’s Gemzar — as well as Novartis AG’s bone drug Zometa and Hoffmann-La Roche Ltd.’s anti-nausea treatment Kytril.
In announcing the charges,...
To view the full article, register now.